Key points are not available for this paper at this time.
The Abbott SARS-CoV-2 assay had fewer false positive and false negative results than the EI assay. However, diagnostic sensitivity was poor in both assays during the first 14 days of symptoms.
Tang et al. (Tue,) studied this question.